Invitae
NVTA
$0.01950
Share price
0.00%
Change (1 day)
-98.61%
Change (1 year)
Invitae (NVTA) - Net assets
Net assets on the balance sheet as of September 2023 : -$1.09 B
According to Invitae
's latest financial reports the company has -$1.09 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Invitae - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.10 B | -96.58% |
| 2021-12-31 | $2.97 B | 50.71% |
| 2020-12-31 | $1.97 B | 420.57% |
| 2019-12-31 | $0.37 B | 134.58% |
| 2018-12-31 | $0.16 B | 32.88% |
| 2017-12-31 | $0.12 B | 22.93% |
| 2016-12-31 | $99.07 M | -28.4% |
| 2015-12-31 | $0.13 B | -265.57% |
| 2014-12-31 | $-83.58 M | 124.18% |
| 2013-12-31 | $-37.28 M | 192.19% |
| 2012-12-31 | $-12.76 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Celldex Therapeutics CLDX | $0.42 B | -139.61% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | $0.47 M | -100.04% | 🇺🇸 USA |
 CareDx CDNA | $0.26 B | -124.12% | 🇺🇸 USA |